Hemorrhage (bleeding): this may occur during treatment with any anticoagulant: the physician should be informed immediately.
Bluish marks at injection sites.
Localized or general allergic reactions.
Thrombocytopenia (abnormally low platelet count level): the physician should be informed immediately.
Rare incidences of severe skin rash at injection sites: consult the physician.
Risk of osteoporosis (bone demineralization leading to bone fragility).
Increased blood level of certain enzymes.
Cases of neuraxial hematomas with the concurrent use of enoxaparin and spinal/epidural anesthesia or spinal puncture which may have resulted in varying degrees of neurological injuries including long term or permanent paralysis have been reported (see Precautions).
Do not hesitate to ask the physician or pharmacist for advice and to report any undesirable effect not mentioned in this monograph.
View ADR Monitoring Form